Deals
Deals dated after 30 September 2026 are still being collected.
Columns
6 of 6 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2026 | ACV Auctions | – | Copart | Acquisition | Information Agent to Copart (acquirer) | Announced | 1,900.0 | Automotive+1 | Evercore (buy-side)Wilson Sonsini Goodrich & Rosati (buy-side)FGS Global (buy-side)J.P. Morgan (sell-side)Davis Polk (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side) | Copart acquisition of ACV Auctions |
| Jul 2026 | Forte Biosciences | – | argenx SE | Acquisition | Information Agent to Avena Merger Sub (acquirer) | Announced | 2,200.0 | Biotech+1 | Goldman Sachs (buy-side)Freshfields (buy-side)Guggenheim Securities (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side) | argenx SE acquisition of Forte Biosciences |
| Jun 2026 | Open Lending | – | ANV Group Holdings | Acquisition | Information Agent to Lakers Acquisition Sub (acquirer) | Completed | – | Insurtech+1 | Paul, Weiss (buy-side)Financial Technology Partners (sell-side)Jones Day (sell-side)Evercore (buy-side) | ANV Group Holdings acquisition of Open Lending |
| Jun 2026 | Nuvalent | – | GSK | Acquisition | The Information Agent to Harmony Row Acquisition Co. (acquirer) | Pending | 10,600.0 | Biotech+2 | Leerink Partners (buy-side)Citi (buy-side)Davis Polk (buy-side)Slaughter and May (buy-side)Centerview Partners (sell-side)Ropes & Gray (sell-side)Jefferies (sell-side)Sidley Austin (sell-side)Sullivan & Cromwell | GSK acquisition of Nuvalent |
| Mar 2026 | Day One Biopharmaceuticals | – | Servier | Acquisition | Information Agent to Servier Pharmaceuticals (acquirer) | Pending | 2,500.0 | Biotech+2 | Goldman Sachs (buy-side)Baker McKenzie (buy-side)Centerview Partners (sell-side)Fenwick & West (sell-side) | Servier acquisition of Day One Biopharmaceuticals |
| Feb 2026 | Arcellx | – | Gilead Sciences | Acquisition | The information agent for the Offer to Gilead Sciences (acquirer) | Announced | 7,800.0 | Biotech+2 | BofA Securities (buy-side)Morgan Stanley (buy-side)Ropes & Gray (buy-side)Centerview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side) | Gilead Sciences acquisition of Arcellx |
Activity
By announcement date; raisings and IPOs by their own date.
Sector of the business bought or funded.
Disclosed value in US dollars.
Most often across the table
- Centerview Partners
3 dealsCompare - Wilson Sonsini Goodrich & Rosati2 dealsCompare
- Guggenheim Securities1 dealCompare
- J.P. Morgan
1 dealCompare - Davis Polk
1 dealCompare - Joele Frank, Wilkinson Brimmer Katcher1 dealCompare
- Fenwick & West1 dealCompare
- Ropes & Gray1 dealCompare
Firms advising the other side of the same deals.